Inactive Instrument
Filament Health Corp. Stock
Stocks
FLHLF
CA31685W1068
Biotechnology & Medical Research
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 40 | 2020-06-07 | |
Tan Thanh Nguyen
DFI | Director of Finance/CFO | 32 | 2024-03-31 |
Ryan Moss
CTO | Chief Tech/Sci/R&D Officer | - | 2021-03-07 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 40 | 2022-12-29 | |
| Director/Board Member | 55 | 2022-08-22 | |
| Director/Board Member | 51 | 2024-03-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/20/26 | Negev Capital Fund One LP
| Sell | Company | 200,000 | 0.0764% | |
| 3/20/26 | Negev Capital Fund One LP
| Other | Company | 0 | 0.0000% | - |
| 3/12/26 | Other | Director | 0 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 26.18K | |
| +2.24% | +8.40% | +58.47% | +69.00% | 68.22B | |
| +4.66% | +8.90% | +16.93% | +85.41% | 59.82B | |
| -0.60% | +1.73% | +24.32% | +94.40% | 56.07B | |
| +2.55% | +15.52% | +30.43% | +120.17% | 47.67B | |
| +2.58% | +7.89% | +32.49% | +45.30% | 45.95B | |
| +4.09% | +6.37% | +228.06% | +899.75% | 43.29B | |
| -0.47% | +9.38% | +27.53% | +52.40% | 35.66B | |
| +3.80% | -1.00% | +98.16% | +66.79% | 34.73B | |
| +1.48% | +6.21% | -38.80% | +395.73% | 25.47B | |
| Average | +2.03% | +7.48% | +53.07% | +203.21% | 46B | |
| Weighted average by Cap. | +2.32% | +7.83% | +54.17% | +182.63% |
Employees
-
